Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-06

Clinical Trial Update: A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Longqi Jiangzhi Decoction for non-alcoholic fatty liver disease and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Longqi Jiangzhi Decoction

Snippet

Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine | Conditions: Hepatic Steatosis | Phase 2 | Status: NOT_YET_RECRUITING